These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8511606)
1. Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients. Abdel-Nabi H; Doerr RJ Semin Nucl Med; 1993 Apr; 23(2):99-113. PubMed ID: 8511606 [TBL] [Abstract][Full Text] [Related]
2. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial. Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278 [TBL] [Abstract][Full Text] [Related]
3. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer. Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756 [TBL] [Abstract][Full Text] [Related]
4. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer. Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723 [TBL] [Abstract][Full Text] [Related]
5. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer. Griffin TW; Brill AB; Stevens S; Collins JA; Bokhari F; Bushe H; Stochl MC; Gionet M; Rusckowski M; Stroupe SD J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759 [TBL] [Abstract][Full Text] [Related]
6. A thousand points of light or just dim bulbs? Radiolabeled antibodies and colorectal cancer imaging. Moffat FL; Gulec SA; Serafini AN; Sfakianakis GN; Pop R; Robinson DS; Franceschi D; Boggs J; Livingstone AS Cancer Invest; 1999; 17(5):322-34. PubMed ID: 10370360 [TBL] [Abstract][Full Text] [Related]
7. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies. De Jager R; Abdel-Nabi H; Serafini A; Pecking A; Klein JL; Hanna MG Semin Nucl Med; 1993 Apr; 23(2):165-79. PubMed ID: 8511602 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study. Wolff BG; Bolton J; Baum R; Chetanneau A; Pecking A; Serafini AN; Fischman AJ; Hoover HC; Klein JL; Wynant GE; Subramanian R; Goroff DK; Hanna MG Dis Colon Rectum; 1998 Aug; 41(8):953-62. PubMed ID: 9715149 [TBL] [Abstract][Full Text] [Related]
12. Operative probe scintimetry with indium and technetium for colorectal cancer. Kuhn JA; Nochumson J J Surg Oncol; 2007 Sep; 96(4):290-6. PubMed ID: 17879338 [TBL] [Abstract][Full Text] [Related]
13. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies. Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891 [TBL] [Abstract][Full Text] [Related]
14. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer. Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688 [TBL] [Abstract][Full Text] [Related]
15. [Radioimmunoscintigraphy of colorectal tumors: state of the art (2)]. Barzen G; Felix R Aktuelle Radiol; 1992 Sep; 2(5):262-70. PubMed ID: 1420384 [TBL] [Abstract][Full Text] [Related]
16. Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: current status and future perspectives. Nabi HA; Doerr RJ Am J Surg; 1992 Apr; 163(4):448-56. PubMed ID: 1558288 [TBL] [Abstract][Full Text] [Related]
17. Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study. Blend MJ; Bhadkamkar VA Cancer Invest; 1998; 16(7):431-41. PubMed ID: 9774949 [TBL] [Abstract][Full Text] [Related]
18. Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate. Chetanneau A; Barbet J; Peltier P; Le Doussal JM; Gruaz-Guyon A; Bernard AM; Resche I; Rouvier E; Bourguet P; Delaage M Nucl Med Commun; 1994 Dec; 15(12):972-80. PubMed ID: 7715897 [TBL] [Abstract][Full Text] [Related]
19. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature. Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]